Quantum量子訊息有限公司

Stress Urinary Incontinence Devices Market

完整報告名稱與涵蓋範圍
Stress Urinary Incontinence Devices Market Size, Share & Trends Analysis Report, By Device Type (Surgical Slings and Mesh Implants, Urethral Bulking Agents, Non-Surgical Devices (Pessaries, Intravaginal Support and Pelvic Floor Trainers), Energy-Based and Neuromodulation Therapies, Artificial Urinary Sphincters and Male Continence Devices), By Patient Type (Female Stress Urinary Incontinence, Male Post-Prostatectomy Incontinence), By End User (Hospitals and Urogynecology Centers, Ambulatory Surgical Centers and Clinics, Home Use and Retail), By Region, and Segment Forecasts, 2026-2035

報告摘要

The stress urinary incontinence devices market covers surgical slings and implants, urethral bulking agents, non-surgical devices such as pessaries, intravaginal supports and pelvic floor trainers, energy-based and neuromodulation therapies and artificial urinary sphincters and male continence devices, used in female stress incontinence and male post-prostatectomy incontinence. Absorbent products, catheters and drugs for overactive bladder are excluded. The market is rebalancing after regulatory actions on transvaginal mesh reduced sling volumes in several countries, shifting demand toward bulking agents with durable efficacy, non-surgical options that women can use at home and conservative pelvic floor therapies supported by connected devices. Growth drivers include an ageing female population, rising diagnosis and treatment-seeking, expanding prostatectomy cohorts creating male demand and reimbursement for in-office bulking procedures. Manufacturers are investing in next-generation bulking materials, minimally invasive male slings and sphincters, app-connected pelvic floor trainers and energy-based therapies, while litigation legacy, evidence requirements and regulatory classification changes influence product strategies. North America and Europe generate most revenue, with Japan, Australia and emerging Asian markets growing as awareness and gynecologic care expand. Competition involves urology and women's health device leaders, bulking agent specialists, pelvic health consumer device companies and regional surgical product manufacturers. The InsightAce study includes revenue forecasts in US$ for all device type, patient type and end user and regional segments across 2026-2035, segment-level trend analysis, competitive positioning assessment and company profiles.

授權報價

Single User$4,500 USD
Enterprise / Global Site Licence$9,500 USD

目錄 Table of Contents

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Stress Urinary Incontinence Devices Market Snapshot Chapter 4. Global Stress Urinary Incontinence Devices Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Market Drivers 4.3. Market Challenges 4.4. Emerging Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis - Porter's Five Forces Analysis 4.7. Competitive Landscape and Market Positioning 4.8. Market Opportunity Analysis Chapter 5. Market Segmentation 1: By Device Type Estimates & Trend Analysis 5.1. Device Type & Market Share, 2026 & 2035 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Device Type: 5.2.1. Surgical Slings and Mesh Implants 5.2.2. Urethral Bulking Agents 5.2.3. Non-Surgical Devices (Pessaries, Intravaginal Support and Pelvic Floor Trainers) 5.2.4. Energy-Based and Neuromodulation Therapies 5.2.5. Artificial Urinary Sphincters and Male Continence Devices Chapter 6. Market Segmentation 2: By Patient Type Estimates & Trend Analysis 6.1. Patient Type & Market Share, 2026 & 2035 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Patient Type: 6.2.1. Female Stress Urinary Incontinence 6.2.2. Male Post-Prostatectomy Incontinence Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis 7.1. End User & Market Share, 2026 & 2035 7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User: 7.2.1. Hospitals and Urogynecology Centers 7.2.2. Ambulatory Surgical Centers and Clinics 7.2.3. Home Use and Retail Chapter 8. Stress Urinary Incontinence Devices Market: Regional Estimates & Trend Analysis 8.1. North America 8.1.1. United States 8.1.2. Canada 8.2. Europe 8.2.1. Germany 8.2.2. United Kingdom 8.2.3. France 8.2.4. Italy 8.2.5. Spain 8.2.6. Rest of Europe 8.3. Asia Pacific 8.3.1. China 8.3.2. Japan 8.3.3. India 8.3.4. South Korea 8.3.5. Australia 8.3.6. Southeast Asia 8.3.7. Rest of Asia Pacific 8.4. Latin America 8.4.1. Brazil 8.4.2. Mexico 8.4.3. Rest of Latin America 8.5. Middle East & Africa 8.5.1. GCC Countries 8.5.2. South Africa 8.5.3. Rest of Middle East & Africa Chapter 9. Competitive Landscape 9.1. Company Market Positioning Analysis 9.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A) Chapter 10. Company Profiles 10.1. Boston Scientific Corporation 10.2. Coloplast A/S 10.3. Axonics, Inc. (Boston Scientific) 10.4. Medtronic plc 10.5. Contura International (Bulkamid, Axonics) 10.6. Laborie Medical Technologies 10.7. Cook Medical 10.8. Caldera Medical, Inc. 10.9. Promedon S.A. 10.10. Elidah, Inc. 10.11. InControl Medical, LLC 10.12. Renovia Inc. 10.13. Atlantic Therapeutics (Innovo) 10.14. Uromedica, Inc. 10.15. Femselect Ltd.

圖表清單 List of Tables & Figures

Table 1. Global Stress Urinary Incontinence Devices Revenue Forecast by Device Type, 2026-2035 (US$ Mn) Figure 1. Global Stress Urinary Incontinence Devices Market Snapshot, 2026 & 2035 Table 2. Global Stress Urinary Incontinence Devices Revenue Forecast by Patient Type, 2026-2035 (US$ Mn) Figure 2. Global Stress Urinary Incontinence Devices Market Share by Patient Type, 2026 & 2035 Table 3. Global Stress Urinary Incontinence Devices Revenue Forecast by End User, 2026-2035 (US$ Mn) Figure 3. Treatment Pathway Shift from Surgical Slings to Bulking Agents and Non-Surgical Options Table 4. North America Stress Urinary Incontinence Devices Revenue by Country, 2026-2035 (US$ Mn) Figure 4. Stress Urinary Incontinence Prevalence, Diagnosis and Treatment Rates by Region Table 5. Europe Stress Urinary Incontinence Devices Revenue by Country, 2026-2035 (US$ Mn) Figure 5. Asia Pacific Stress Urinary Incontinence Devices Growth Opportunity Analysis Table 6. Asia Pacific Stress Urinary Incontinence Devices Revenue by Country, 2026-2035 (US$ Mn) Figure 6. Male Continence Device Demand Linked to Prostatectomy Volumes, 2026-2035 Table 7. Latin America and Middle East & Africa Stress Urinary Incontinence Devices Revenue Forecast, 2026-2035 (US$ Mn) Figure 7. Competitive Positioning of Key Stress Urinary Incontinence Devices Market Participants

提及公司

Boston Scientific CorporationColoplast A/SAxonics, Inc. (Boston Scientific)Medtronic plcContura International (Bulkamid, Axonics)Laborie Medical TechnologiesCook MedicalCaldera Medical, Inc.Promedon S.A.Elidah, Inc.InControl Medical, LLCRenovia Inc.Atlantic Therapeutics (Innovo)Uromedica, Inc.Femselect Ltd.

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們